Press Releases

Featured Press Releases

BIO Statement on Resignation of Peter Marks from…

John Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement regarding the resignation of Peter Marks from the FDA: “Under the extraordinary leadership of Dr. Peter Marks, the FDA…

Learn more

New survey: U.S. biotechs warn tariffs could…

WASHINGTON (March 26, 2025) -- Today, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the significant, global integration of the biomedical supply chain. According to the findings, nearly 90…

Learn more

BIO Releases New Report Underscoring the Massive…

WASHINGTON D.C. – Today, the Biotechnology Innovation Organization (BIO), in partnership with Kearney, a global management consulting firm, released a first-of-its-kind report that assesses the significant economic impact of the U.S. bioeconomy…

Learn more

BIO Statement on Resignation of Peter Marks from the FDA

March 29, 2025

New survey: U.S. biotechs warn tariffs could impede access to cures, stifle innovation

March 26, 2025

BIO Releases New Report Underscoring the Massive Economic Power of the American Bioeconomy

March 24, 2025

BIO Applauds Introduction of Bipartisan Bill to Eliminate the Pill Penalty

February 25, 2025

Legislation will help spur the development of lifesaving treatments and cures WASHINGTON D.C. (February 25, 2025) – John Crowley, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement…

BIO Applauds Introduction of Bipartisan ORPHAN Cures Act

February 5, 2025

Urges Congress to support rare disease patients & support the billWASHINGTON, D.C. (February 5, 2025) – John F. Crowley, President & CEO of the Biotechnology Innovation Organization (BIO), today released the following statement after…

BIO Statement on New List of Medicines Targeted for Government Price Setting

January 17, 2025

WASHINGTON, D.C. (January 17, 2025) – The Biotechnology Innovation Organization (BIO) today released the following statement after the Biden administration released a list of 15 medicines being selected for government price setting:“In the final…

BIO Statement on the USMCA Biotech Corn Dispute Panel’s Final Ruling

December 20, 2024

Today the dispute settlement panel formed under the United States-Mexico-Canada Agreement (USMCA) issued a final ruling related to Mexico's restrictions on the importation of genetically modified (GM) corn. In response, John Crowley, President…

BIO Applauds the Inclusion of Important Health Care and Agriculture Priorities and Programs in Year-end Government Funding Bill

December 17, 2024

John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), today released the following statement ahead of an expected vote in the U.S. House of Representatives on a year-end government funding bill that includes many…

BIO Appoints Veteran Communications Leader Sarah Alspach as Executive Vice President and Chief Communications Officer

December 9, 2024

Today, the Biotechnology Innovation Organization (BIO) named Sarah Alspach as its new executive vice president and chief communications officer. Alspach, a communications veteran, will join BIO’s senior leadership team. Her first day will be…

New Report Finds Bioscience Sector Generates Over $3 Trillion for U.S. Economy

December 2, 2024

Today, the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) released new national and state-level data on the U.S. bioscience industry's economic performance, its impacts, and its geographic…

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.